BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

719 related articles for article (PubMed ID: 17803871)

  • 21. Pneumocystis jirovecii pneumonia in kidney transplantation.
    Goto N; Oka S
    Transpl Infect Dis; 2011 Dec; 13(6):551-8. PubMed ID: 22093172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pneumocystis jirovecii pneumonia in liver transplant recipients in an era of routine prophylaxis.
    Andreasen PB; Rezahosseini O; Møller DL; Wareham NE; Thomsen MT; Houmami R; Knudsen AD; Knudsen J; Kurtzhals JAL; Rostved AA; Pedersen CR; Rasmussen A; Nielsen SD
    Immun Inflamm Dis; 2022 Jan; 10(1):93-100. PubMed ID: 34713963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of Pneumocystis jirovecii pneumonia in HIV-infected patients: a review.
    Huang YS; Yang JJ; Lee NY; Chen GJ; Ko WC; Sun HY; Hung CC
    Expert Rev Anti Infect Ther; 2017 Sep; 15(9):873-892. PubMed ID: 28782390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pneumocystis pneumonia in a renal transplant recipient].
    Özkoç S; İnceboz T; Sıfıl A; Tuncay S; Akisü Ç
    Turkiye Parazitol Derg; 2010; 34(4):186-9. PubMed ID: 21391190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pneumocystis jirovecii pneumonia in solid organ transplant recipients: a descriptive analysis for the Swiss Transplant Cohort.
    Neofytos D; Hirzel C; Boely E; Lecompte T; Khanna N; Mueller NJ; Boggian K; Cusini A; Manuel O; van Delden C;
    Transpl Infect Dis; 2018 Dec; 20(6):e12984. PubMed ID: 30155950
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of trimethoprim-sulfamethoxazole for the prevention of pneumocystis pneumonia in human immunodeficiency virus-negative immunodeficient patients: A systematic review and meta-analysis.
    Li R; Tang Z; Liu F; Yang M
    PLoS One; 2021; 16(3):e0248524. PubMed ID: 33765022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A systematic review of two different trimetoprim-sulfamethoxazole regimens used to prevent Pneumocystis jirovecii and no prophylaxis at all in transplant recipients: appraising the evidence.
    Di Cocco P; Orlando G; Bonanni L; D'Angelo M; Clemente K; Greco S; Gravante G; Madeddu F; Scelzo C; Famulari A; Pisani F
    Transplant Proc; 2009 May; 41(4):1201-3. PubMed ID: 19460516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluating a new strategy for prophylaxis to prevent Pneumocystis carinii pneumonia in HIV-exposed infants in Thailand. Bangkok Collaborative Perinatal HIV Transmission Study Group.
    Chokephaibulkit K; Chuachoowong R; Chotpitayasunondh T; Chearskul S; Vanprapar N; Waranawat N; Mock P; Shaffer N; Simonds RJ
    AIDS; 2000 Jul; 14(11):1563-9. PubMed ID: 10983643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pneumocystis jirovecii Pneumonia in Patients With Metastatic Prostate Cancer on Corticosteroids for Malignant Spinal Cord Compression: Two Case Reports and a Guideline Review.
    Duarte C; Gilbert D; Sheridan AD; PharmaD SDW; Lam ET
    Oncology (Williston Park); 2020 Mar; 34(3):. PubMed ID: 32212136
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conventional-dose Versus Half-dose Sulfamethoxazole-trimethoprim for the Prophylaxis of Pneumocystis Pneumonia in Patients with Systemic Rheumatic Disease: A Non-blind, Randomized Controlled Trial.
    Abe Y; Fujibayashi K; Nishizaki Y; Yanagisawa N; Nojiri S; Nakano S; Tada K; Yamaji K; Tamura N
    Acta Med Okayama; 2019 Feb; 73(1):85-89. PubMed ID: 30820060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High rates of Pneumocystis carinii pneumonia in allogeneic blood and marrow transplant recipients receiving dapsone prophylaxis.
    Souza JP; Boeckh M; Gooley TA; Flowers ME; Crawford SW
    Clin Infect Dis; 1999 Dec; 29(6):1467-71. PubMed ID: 10585797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Failure of trimethoprim/sulfamethoxazole prophylaxis for Pneumocystis carinii pneumonia with concurrent leucovorin use.
    Razavi B; Lund B; Allen BL; Schlesinger L
    Infection; 2002 Jan; 30(1):41-2. PubMed ID: 11876516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors for Pneumocystis jirovecii pneumonia in kidney transplant recipients and appraisal of strategies for selective use of chemoprophylaxis.
    de Boer MG; Kroon FP; le Cessie S; de Fijter JW; van Dissel JT
    Transpl Infect Dis; 2011 Dec; 13(6):559-69. PubMed ID: 21689251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prophylaxis and Treatment of Pneumocystis jiroveci Pneumonia in Lymphoma Patients Subjected to Rituximab-Contained Therapy: A Systemic Review and Meta-Analysis.
    Jiang X; Mei X; Feng D; Wang X
    PLoS One; 2015; 10(4):e0122171. PubMed ID: 25909634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute psychosis related to use of trimethoprim/sulfamethoxazole in the treatment of HIV-infected patients with Pneumocystis jirovecii pneumonia: a multicentre, retrospective study.
    Lee KY; Huang CH; Tang HJ; Yang CJ; Ko WC; Chen YH; Lee YC; Hung CC
    J Antimicrob Chemother; 2012 Nov; 67(11):2749-54. PubMed ID: 22821870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV-infection.
    Briel M; Bucher HC; Boscacci R; Furrer H
    Cochrane Database Syst Rev; 2006 Jul; (3):CD006150. PubMed ID: 16856118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Late-onset Pneumocystis jirovecii pneumonia in solid organ transplant recipients.
    Perez-Ordoño L; Hoyo I; Sanclemente G; Ricart MJ; Cofan F; Perez-Villa F; de la Bellacasa JP; Moreno A; Cervera C
    Transpl Infect Dis; 2014 Apr; 16(2):324-8. PubMed ID: 24456244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preventive effect of sulfamethoxasole-trimethoprim on Pneumocystis jiroveci pneumonia in patients with interstitial pneumonia.
    Enomoto T; Azuma A; Matsumoto A; Nei T; Fujita K; Hattori K; Saito Y; Abe S; Usuki J; Kudoh S
    Intern Med; 2008; 47(1):15-20. PubMed ID: 18175999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Should patients with malignancy receive chemoprophylaxis against Pneumocystis jirovecii pneumonia?
    Barbounis V
    Nat Clin Pract Oncol; 2005 Oct; 2(10):490-1. PubMed ID: 16205763
    [No Abstract]   [Full Text] [Related]  

  • 40. Pneumocystis jirovecii pneumonia prophylaxis in immunocompromised patients with systemic autoimmune diseases.
    Braga BP; Prieto-González S; Hernández-Rodríguez J
    Med Clin (Barc); 2019 Jun; 152(12):502-507. PubMed ID: 30853123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.